Hoban DJ - Search Results

1

Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.

Zhanel GG, Hisanaga T, Nichol K, Wierzbowski A, Hoban DJ. Zhanel GG, et al. Among authors: hoban dj. Expert Opin Emerg Drugs. 2003 Nov;8(2):297-321. doi: 10.1517/14728214.8.2.297. Expert Opin Emerg Drugs. 2003. PMID: 14661991 Review.

2

In vitro pharmacodynamic modelling simulating free serum concentrations of fluoroquinolones against multidrug-resistant Streptococcus pneumoniae.

Zhanel GG, Walters M, Laing N, Hoban DJ. Zhanel GG, et al. Among authors: hoban dj. J Antimicrob Chemother. 2001 Apr;47(4):435-40. doi: 10.1093/jac/47.4.435. J Antimicrob Chemother. 2001. PMID: 11266416

3

Review of macrolides and ketolides: focus on respiratory tract infections.

Zhanel GG, Dueck M, Hoban DJ, Vercaigne LM, Embil JM, Gin AS, Karlowsky JA. Zhanel GG, et al. Among authors: hoban dj. Drugs. 2001;61(4):443-98. doi: 10.2165/00003495-200161040-00003. Drugs. 2001. PMID: 11324679 Review.

4

Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.

Hoban DJ, Wierzbowski AK, Nichol K, Zhanel GG. Hoban DJ, et al. Antimicrob Agents Chemother. 2001 Jul;45(7):2147-50. doi: 10.1128/AAC.45.7.2147-2150.2001. Antimicrob Agents Chemother. 2001. PMID: 11408241 Free PMC article.

5

Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).

Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG. Wierzbowski AK, et al. Among authors: hoban dj. J Antimicrob Chemother. 2007 Oct;60(4):733-40. doi: 10.1093/jac/dkm273. Epub 2007 Aug 2. J Antimicrob Chemother. 2007. PMID: 17673477

6

A critical review of the fluoroquinolones: focus on respiratory infections.

Zhanel GG, Ennis K, Vercaigne L, Walkty A, Gin AS, Embil J, Smith H, Hoban DJ. Zhanel GG, et al. Among authors: hoban dj. Drugs. 2002;62(1):13-59. doi: 10.2165/00003495-200262010-00002. Drugs. 2002. PMID: 11790155 Review.

7

Ketolides in the treatment of respiratory infections.

Zhanel GG, Hoban DJ. Zhanel GG, et al. Among authors: hoban dj. Expert Opin Pharmacother. 2002 Mar;3(3):277-97. doi: 10.1517/14656566.3.3.277. Expert Opin Pharmacother. 2002. PMID: 11866679 Review.

8

Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.

Zhanel GG, Roberts D, Waltky A, Laing N, Nichol K, Smith H, Noreddin A, Bellyou T, Hoban DJ. Zhanel GG, et al. Among authors: hoban dj. J Antimicrob Chemother. 2002 May;49(5):807-12. doi: 10.1093/jac/dkf022. J Antimicrob Chemother. 2002. PMID: 12003975

9

The ketolides: a critical review.

Zhanel GG, Walters M, Noreddin A, Vercaigne LM, Wierzbowski A, Embil JM, Gin AS, Douthwaite S, Hoban DJ. Zhanel GG, et al. Among authors: hoban dj. Drugs. 2002;62(12):1771-804. doi: 10.2165/00003495-200262120-00006. Drugs. 2002. PMID: 12149046 Review.

10

Pharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations.

Noreddin AM, Roberts D, Nichol K, Wierzbowski A, Hoban DJ, Zhanel GG. Noreddin AM, et al. Among authors: hoban dj. Antimicrob Agents Chemother. 2002 Dec;46(12):4029-34. doi: 10.1128/AAC.46.12.4029-4034.2002. Antimicrob Agents Chemother. 2002. PMID: 12435719 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters